| Drug Name |
Prednisolone |
| Drug ID |
BADD_D01831 |
| Description |
Prednisolone is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463]
Prednisolone was granted FDA approval on 21 June 1955.[L9431] |
| Indications and Usage |
For the treatment of primary or secondary adrenocortical insufficiency, such as congenital adrenal hyperplasia, thyroiditis. Also used to treat psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, acute gouty arthritis and epicondylitis. Also indicated for treatment of systemic lupus erythematosus, pemphigus and acute rhematic carditis. Can be used in the treatment of leukemias, lymphomas, thrombocytopenia purpura and autoimmune hemolytic anemia. Can be used to treat celiac disease, insulin resistance, ulcerative colitis and liver disorders. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A07EA01; C05AA04; D07AA03; D07XA02; H02AB06; R01AD02; S01BA04; S01CB02; S02BA03; S03BA02 |
| DrugBank ID |
DB00860
|
| KEGG ID |
D00472
|
| MeSH ID |
D011239
|
| PubChem ID |
5755
|
| TTD Drug ID |
D0D1SG
|
| NDC Product Code |
0395-8164; 51927-0197; 22552-0052; 0527-5406; 82298-104; 50383-042; 64958-0097; 60592-911; 50090-0655; 63187-466; 65089-0038; 67296-1656; 23594-505; 51927-1148; 61919-291; 51927-0234; 57582-004; 38779-0150; 82298-106; 82298-105; 68788-9096; 60722-3001; 73534-505; 49452-5980 |
| Synonyms |
Prednisolone | Predate | Predonine | Di-Adreson-F | Di Adreson F | DiAdresonF |
